APOL1 high-risk variants testing has a role in identifying people at higher risk of developing kidney disease for more aggressive management of risk factors, counseling of potential kidney donors, and selection of candidates for therapies targeting APOL1.4 Here, APOL1 is linked to kidney disorder.